GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » EV-to-FCF

PTKFY (PT Kalbe Farma Tbk) EV-to-FCF : 20.24 (As of Dec. 13, 2024)


View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Kalbe Farma Tbk's Enterprise Value is $4,672 Mil. PT Kalbe Farma Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $231 Mil. Therefore, PT Kalbe Farma Tbk's EV-to-FCF for today is 20.24.

The historical rank and industry rank for PT Kalbe Farma Tbk's EV-to-FCF or its related term are showing as below:

PTKFY' s EV-to-FCF Range Over the Past 10 Years
Min: 17.94   Med: 54.1   Max: 433.65
Current: 18

During the past 13 years, the highest EV-to-FCF of PT Kalbe Farma Tbk was 433.65. The lowest was 17.94. And the median was 54.10.

PTKFY's EV-to-FCF is ranked better than
63.59% of 552 companies
in the Drug Manufacturers industry
Industry Median: 25.86 vs PTKFY: 18.00

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), PT Kalbe Farma Tbk's stock price is $20.75. PT Kalbe Farma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $0.864. Therefore, PT Kalbe Farma Tbk's PE Ratio (TTM) for today is 24.02.


PT Kalbe Farma Tbk EV-to-FCF Historical Data

The historical data trend for PT Kalbe Farma Tbk's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk EV-to-FCF Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 142.93 21.27 39.20 237.58 42.46

PT Kalbe Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.98 42.46 25.79 20.84 21.86

Competitive Comparison of PT Kalbe Farma Tbk's EV-to-FCF

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's EV-to-FCF falls into.



PT Kalbe Farma Tbk EV-to-FCF Calculation

PT Kalbe Farma Tbk's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=4671.773/230.798
=20.24

PT Kalbe Farma Tbk's current Enterprise Value is $4,672 Mil.
PT Kalbe Farma Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $231 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kalbe Farma Tbk  (OTCPK:PTKFY) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

PT Kalbe Farma Tbk's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=20.75/0.864
=24.02

PT Kalbe Farma Tbk's share price for today is $20.75.
PT Kalbe Farma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.864.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PT Kalbe Farma Tbk EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk Headlines

No Headlines